Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.43 |
| ▸ | GRIA3 | P42263 | 3/20 | 0.43 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.43 |
| ▸ | GRIK4 | Q16099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2238814 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL7876588 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL197231 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL7873502 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL7876596 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| SCHEMBL29035113 | 1.00 | DPP4 (0.50) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL3418559 | 0.98 | DPP4 (0.49) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL7383848 | 0.98 | DPP4 (0.49) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL18103704 | 0.98 | DPP4 (0.49) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 | |
| Hydrochloric Acid SCHEMBL3418556 | 0.98 | DPP4 (0.49) | DPP4CYP1A2CYP2D6ALOX15CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105126-A1 | DNA-BASED MECHANOSENSITIVE DELIVERY AGENTS AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2026-05-21 | — | — | WO | claimed |
| US-20260115253-A1 | VISCOUS COMPOSITION FOR TREATING ISCHEMIA | UNIV NAT CHENG KUNG (TW) | 2026-04-30 | — | — | US | claimed |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA. (PT) | 2025-02-13 | — | — | US | claimed |
| CN-118973593-A | Novel method for decellularizing extracellular matrix | 瑞根克斯科学股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-113271960-B | Dry powder inhalation formulations and their use for treating lung | 布鲁塞尔自由大学 | 2024-11-05 | — | — | CN | claimed |
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | EXTREMOCHEM, LDA (PT) | 2024-09-24 | — | — | US | claimed |
| CN-117295489-A | Compositions, devices and methods for treating respiratory disorders | 呼吸解决方案股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116782865-A | Atomic layer deposition coated pharmaceutical packages, improved syringes and vials, e.g., for lyophilization/cold chain drugs/vaccines | SIO2医药产品公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116406377-A | anti-NOTCH 2 antibodies and methods of use thereof | 基因泰克公司 | 2023-07-07 | — | — | CN | claimed |
| CN-115786458-A | Genome DNA methylated fragment targeted enrichment and sequencing method | 河南大学 | 2023-03-14 | — | — | CN | claimed |
| CN-101462996-B | Preparation of 4-cyclohexyl proline derivative | SHANGHAI INST PHARM INDUSTRY | 2011-04-20 | — | — | CN | claimed |
| US-7884074-B2 | Compounds and methods for prevention and/or treatment of inflammation using the same | Ikaria Development Subsidiary Two, LLC (US) | 2011-02-08 | — | — | US | claimed |
| EP-2274328-A1 | PEPTIDES, PEPTIDOMIMETICS AND DERIVATIVES THEREOF, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | Fibrex Medical Research & Development GmbH (AT) | 2011-01-19 | — | — | EP | claimed |
| US-20100099602-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE FOR THE PREVENTION AND TREATMENT OF HYPOXIC INJURY | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2010-04-22 | — | — | US | claimed |
| WO-2010043972-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE FOR THE PREVENTION AND TREATMENT OF HYPOXIC INJURY | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2010-04-22 | — | — | WO | claimed |
| WO-2010034041-A1 | PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2010-04-01 | — | — | WO | claimed |
| US-20100081787-A1 | PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2010-04-01 | — | — | US | claimed |
| US-20090286739-A1 | PEPTIDES, PEPTIDOMIMETICS AND DERIVATIVES THEREOF, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2009-11-19 | — | — | US | claimed |
| WO-2009137850-A1 | PEPTIDES, PEPTIDOMIMETICS AND DERIVATIVES THEREOF, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH (AT) | 2009-11-19 | — | — | WO | claimed |
| CN-101462996-A | Preparation of 4-cyclohexyl proline derivative | SHANGHAI INST PHARM INDUSTRY (CN) | 2009-06-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | FUT6, GUSB, UGGT1 | DPP4 366/4885CYP1A2 2169/4885CYP2D6 233/4885 |
| US-20100099602-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE FOR THE PREVENTION AND TREATMENT OF HYPOXIC INJURY | HIF1AN, HIF1A, EGLN3 | DPP4 975/4885CYP1A2 2264/4885CYP2D6 2872/4885 |
| US-20260115253-A1 | VISCOUS COMPOSITION FOR TREATING ISCHEMIA | SERPINE1, CD44, SERPINB8 | DPP4 3831/4885CYP1A2 3798/4885CYP2D6 4525/4885 |
| US-20100081787-A1 | PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | NGLY1, GHRHR, GHSR | DPP4 3514/4885CYP1A2 2694/4885CYP2D6 3352/4885 |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | DPP4 366/4885CYP1A2 2169/4885CYP2D6 233/4885 |
| US-20090286739-A1 | PEPTIDES, PEPTIDOMIMETICS AND DERIVATIVES THEREOF, THE MANUFACTURING THEREOF AS WELL AS THEIR USE FOR PREPARING A THERAPEUTICALLY AND/OR PREVENTIVELY ACTIVE PHARMACEUTICAL COMPOSITION | NPR3, RXFP3, RXFP1 | DPP4 2036/4885CYP1A2 2247/4885CYP2D6 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.